Bayer/GSK Levitra Sales Top $100 Mil.; New ED Patient Share Growing
Executive Summary
More than 40% of new prescriptions for Bayer/ GlaxoSmithKline's Levitra are for previously undiagnosed erectile dysfunction patients, Bayer CFO Klaus Kuhn told investors Nov. 11